http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103958515-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
filingDate 2012-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85e9f784f7e260b12d3b82a0fa4e6f1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abb92e3a7b11b9e2abe57970a87d57e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97e2a09eb5d5cfb5cae2d5353103fa18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d4ce3dba319eedbe1b1b2fc8b844641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4117e02ea978e8e93e58fb72ad80fd29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d51567ef473ead7f8f498e3170cb9d3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b9203063f01ad58135a49fd4bdf159d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3beeb2f3ffa281d5696762a8e40f00a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a878a283848e0176c595aa76bdf205e7
publicationDate 2014-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103958515-A
titleOfInvention Amino-substituted imidazopyridazines
abstract The present invention relates to amino-substituted imidazopyridazine compounds of general formula (I) (wherein A, R1, R3 and n are as defined in the claims), methods for preparing said compounds, pharmaceutical compositions comprising said compounds and combinations, and the use of said compound as a single agent or in combination with other active ingredients for the preparation of a pharmaceutical composition for the treatment or prevention of diseases (especially hyperproliferative disorders and/or angiogenic disorders).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104487440-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107108636-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104487440-B
priorityDate 2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007093490-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008030579-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007147646-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101594909-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468119334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466340149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466126054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466340144

Total number of triples: 41.